More News
28 September 2017
OSE Immunotherapeutics Signs a License Option Agreement with Inserm to Develop a New Cancer Immunotherapy Targeting Myeloid Cells28 September 2017
Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based Assays for Clinical Target Validation in Inflammatory Bowel Disease28 September 2017
Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome28 September 2017
Amgen And Simcere Announce Strategic Collaboration To Co-Develop And Commercialize Biosimilars In China26 September 2017
Genocea Announces Strategic Shift to Immuno-oncology and the Development of Neoantigen Cancer Vaccines26 September 2017
Glythera Licenses Novel Payload Class from Cancer Research UK for the Development of Next-Generation Antibody Drug Conjugates26 September 2017
SpringWorks Therapeutics Launches with $103M in Series A Funding and Rights to Four Clinical Programs21 September 2017
Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets21 September 2017
Cellectar Biosciences Enters into Strategic Collaboration with Onconova Therapeutics to Develop New Phospholipid Drug Conjugates21 September 2017
Spark Therapeutics Enters into Licensing Agreement with Genethon21 September 2017
Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.21 September 2017
Glythera and IONTAS Enter into License Agreement for the Development of Multiple Antibodies for Next-Generation Antibody Drug Conjugates18 September 2017
Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases14 September 2017
MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia Therapies14 September 2017
Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties14 September 2017
Bristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology13 September 2017
Geom Therapeutics Announces Agreement with National Institute of Allergy and Infectious Diseases (NIAID) for Clinical Advancement of GT-112 September 2017
AbCellera Launches Antibody Discovery Collaboration with GSK7 September 2017
Gritstone Oncology Secures $92.7 Million in Series B Financing7 September 2017
Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments7 September 2017
Zealand and Orbit Discovery enter into research collaborationNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports